posted on 2021-12-27, 19:36authored byYuki Nagano, Jan Vincent V. Arafiles, Keiko Kuwata, Yoshimasa Kawaguchi, Miki Imanishi, Hisaaki Hirose, Shiroh Futaki
Stapled peptides are a promising
class of conformationally restricted
peptides for modulating protein–protein interactions (PPIs).
However, the low membrane permeability of these peptides is an obstacle
to their therapeutic applications. It is common that only a few hydrophobic
amino acid residues are mandatory for stapled peptides to bind to
their target proteins. Hoping to create a novel class of membrane-permeable
PPI inhibitors, the phenylalanine, tryptophan, and leucine residues
that play a critical role in inhibiting the p53-HDM2 interaction were
grafted into the framework of CADY2a cell-penetrating peptide
(CPP) having a helical propensity. Two analogues (CADY-3FWL and CADY-10FWL)
induced apoptotic cell death but lacked the intended HDM2 interaction.
Pull-down experiments followed by proteomic analysis led to the elucidation
of nesprin-2 as a candidate binding target. Nesprin-2 is considered
to play a role in the nuclear translocation of β-catenin upon
activation of the Wnt signaling pathway, which leads to the expression
of antiapoptosis proteins and cell survival. Cells treated with the
two analogues showed decreased nuclear localization of β-catenin
and reduced mRNA expression of related antiapoptotic proteins. These
data suggest inhibition of β-catenin nuclear translocation as
a possible mode of action of the described cell-penetrating stapled
peptides.